Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Long acting beta agonists"'
Autor:
Jorge Arencibia-Borrego, Javier Sanchez Lora, Joan Serra-Batlles, Juan A. Riesco Miranda, Juan Enrique Cimas, Rosa Malo de Molina, Lucía Regadera, Javier Nuevo
Publikováno v:
Medicina Clínica Práctica, Vol 6, Iss 2, Pp 100367- (2023)
Resumen: Objetivo: el objetivo del estudio fue describir el perfil epidemiológico, clínico y calidad de vida de los pacientes con enfermedad pulmonar obstructiva crónica, estables, en tratamiento de mantenimiento con un agonista β2 adrenérgico d
Externí odkaz:
https://doaj.org/article/5ef506b9dd314817bade874d8e03cb54
Publikováno v:
Медицинский совет, Vol 0, Iss 21-1, Pp 80-85 (2022)
Chronic obstructive pulmonary disease (COPD) is one of the most important problems of modern medicine associated with a high mortality rate, high costs of treatment and relief of exacerbations of COPD. The main objectives of COPD treatment are sympto
Externí odkaz:
https://doaj.org/article/fee3226e1cd847e8b61cb908556c941a
Publikováno v:
Медицинский совет, Vol 0, Iss 21, Pp 90-95 (2021)
Chronic obstructive pulmonary disease (COPD) is currently one of the most socially significant diseases that leads to a significant decrease in the daily activity and productivity of patients, as well as their rapid invalidization. In this regard, it
Externí odkaz:
https://doaj.org/article/ae992e8264694b298879349c98d7dc0f
Autor:
Richard Beasley, James Harper, Grace Bird, Harriette Dunphy, Alex Semprini, Ian D. Pavord, Alberto Papi, Mark Weatherall
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background and objective The dose-response relationship of inhaled corticosteroid (ICS)/fast-onset long acting beta agonist (LABA) reliever therapy has not been formally addressed. The objective of this retrospective analysis is to ascertain
Externí odkaz:
https://doaj.org/article/127ad60dad3d450ba34cda8ccaf3d542
Autor:
Fugui Yan, Wen Li, Wei‐jie Guan, Min Chen, Chen Qiu, Wei Tang, Xiansheng Liu, Xudong Xiang, Jing Li, Meiling Jin, Yuanrong Dai, Ping Chen, Xiaohong Wu, Zhongmin Qiu, Liang Dong, Limin Zhao, Xiaoping Lin, Changgui Wu, Bin Wu, Yalian Yuan, Fei Shi, Ting Zhang, Jun Zhou, Min Xie, Xiaoyu Fang, Hongliang Zhang, Bing Xiao, Mo Xian, Jian Wang, Zhangwei Qiu, Jie Lin, Bingbing Ji, Yong Zhou, Yu Li, Chunhong Liu, Yiping Chen, Yiming Zeng, Lingli Liu, Wen Hua, Huaqiong Huang, Jiesen Zhou, Yue Hu, Luanqing Che, Songmin Ying, Zhihua Chen, Nanshan Zhong, Huahao Shen
Publikováno v:
Clinical and Translational Medicine, Vol 10, Iss 5, Pp n/a-n/a (2020)
Abstract Background Asthmatic patients with chest tightness as their only presenting symptom (chest tightness variant asthma [CTVA]) have clinical characteristics of eosinophilic airway inflammation similar to those of classic asthma (CA); however, w
Externí odkaz:
https://doaj.org/article/6354d8a6c3854933bd4ebe4f2d46df97
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 14, Iss 1, Pp 1-4 (2018)
Abstract Background Sputum induction with hypertonic saline in obstructive airway diseases is generally safe. However, saline induces bronchoconstriction in some patients despite pre-medication with Salbutamol. Our objectives were to investigate the
Externí odkaz:
https://doaj.org/article/56daf4e985d84d0b8e99e3ca1d3ad725
Autor:
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov
Publikováno v:
Фармакоэкономика, Vol 10, Iss 2, Pp 22-30 (2017)
The recently introduced novel drug combinations for the treatment of COPD are based on long-acting beta-agonists (vilantererol / umeclidinum bromide) and long-acting anticholinergics (olodaterol / tiotropium bromide). In addition to their beneficial
Externí odkaz:
https://doaj.org/article/1d4f89ad2f9c43b4acf1d67df41135bb
Autor:
N. L. Pogudina, E. G. Kosolapov, F. S. Kochenkov, A. V. Karaulov, N. L. Bondarenko, D. V. Blinov
Publikováno v:
Фармакоэкономика, Vol 10, Iss 2, Pp 12-21 (2017)
Comparative pharmacoeconomic analysis of fixed-dose combinations (FDC) vilanterol / fluticasone furoate vs budesonide / formoterol was needed to identify the preferable FDC for asthma management.Study objective: to identify the preferable FDC of inha
Externí odkaz:
https://doaj.org/article/510e92d40fef4d478021f3c82e9a7a72
Publikováno v:
Фармакоэкономика, Vol 10, Iss 2, Pp 31-40 (2017)
In accordance with currently accepted recommendations for the diagnosis and treatment of chronic obstructive pulmonary disease (COPD), both monotherapy with long-acting anticholinergics (LAAC) or combined therapy (LAAC / long-acting beta-agonists, LA
Externí odkaz:
https://doaj.org/article/45a3d1dabd4645ce9114c79e5fe8b0e7
Autor:
Faeq R. Kukhon, Emir Festic
Publikováno v:
Medical Sciences, Vol 9, Iss 2, p 34 (2021)
Community-acquired pneumonia is still a major cause of morbidity and mortality worldwide. Since the inflammatory response induced by the immune system is often a major contributor to the lung injury, it becomes reasonable to assess the potential bene
Externí odkaz:
https://doaj.org/article/949160fb1b9345c5a3770c3fb2855032